These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
296 related articles for article (PubMed ID: 21532615)
1. Control of tumor and microenvironment cross-talk by miR-15a and miR-16 in prostate cancer. Musumeci M; Coppola V; Addario A; Patrizii M; Maugeri-Saccà M; Memeo L; Colarossi C; Francescangeli F; Biffoni M; Collura D; Giacobbe A; D'Urso L; Falchi M; Venneri MA; Muto G; De Maria R; Bonci D Oncogene; 2011 Oct; 30(41):4231-42. PubMed ID: 21532615 [TBL] [Abstract][Full Text] [Related]
2. Regulatory Role of mir-203 in Prostate Cancer Progression and Metastasis. Saini S; Majid S; Yamamura S; Tabatabai L; Suh SO; Shahryari V; Chen Y; Deng G; Tanaka Y; Dahiya R Clin Cancer Res; 2011 Aug; 17(16):5287-98. PubMed ID: 21159887 [TBL] [Abstract][Full Text] [Related]
3. The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities. Bonci D; Coppola V; Musumeci M; Addario A; Giuffrida R; Memeo L; D'Urso L; Pagliuca A; Biffoni M; Labbaye C; Bartucci M; Muto G; Peschle C; De Maria R Nat Med; 2008 Nov; 14(11):1271-7. PubMed ID: 18931683 [TBL] [Abstract][Full Text] [Related]
4. miR-205 Exerts tumor-suppressive functions in human prostate through down-regulation of protein kinase Cepsilon. Gandellini P; Folini M; Longoni N; Pennati M; Binda M; Colecchia M; Salvioni R; Supino R; Moretti R; Limonta P; Valdagni R; Daidone MG; Zaffaroni N Cancer Res; 2009 Mar; 69(6):2287-95. PubMed ID: 19244118 [TBL] [Abstract][Full Text] [Related]
5. Molecular insights into prostate cancer progression: the missing link of tumor microenvironment. Chung LW; Baseman A; Assikis V; Zhau HE J Urol; 2005 Jan; 173(1):10-20. PubMed ID: 15592017 [TBL] [Abstract][Full Text] [Related]
6. Downregulation of miR-132 by promoter methylation contributes to pancreatic cancer development. Zhang S; Hao J; Xie F; Hu X; Liu C; Tong J; Zhou J; Wu J; Shao C Carcinogenesis; 2011 Aug; 32(8):1183-9. PubMed ID: 21665894 [TBL] [Abstract][Full Text] [Related]
8. MicroRNA-330 acts as tumor suppressor and induces apoptosis of prostate cancer cells through E2F1-mediated suppression of Akt phosphorylation. Lee KH; Chen YL; Yeh SD; Hsiao M; Lin JT; Goan YG; Lu PJ Oncogene; 2009 Sep; 28(38):3360-70. PubMed ID: 19597470 [TBL] [Abstract][Full Text] [Related]
9. miR-106a-mediated malignant transformation of cells induced by anti-benzo[a]pyrene-trans-7,8-diol-9,10-epoxide. Jiang Y; Wu Y; Greenlee AR; Wu J; Han Z; Li X; Zhao Y Toxicol Sci; 2011 Jan; 119(1):50-60. PubMed ID: 20889678 [TBL] [Abstract][Full Text] [Related]
10. Systematic analysis of microRNAs targeting the androgen receptor in prostate cancer cells. Östling P; Leivonen SK; Aakula A; Kohonen P; Mäkelä R; Hagman Z; Edsjö A; Kangaspeska S; Edgren H; Nicorici D; Bjartell A; Ceder Y; Perälä M; Kallioniemi O Cancer Res; 2011 Mar; 71(5):1956-67. PubMed ID: 21343391 [TBL] [Abstract][Full Text] [Related]
11. miR-203 reverses chemoresistance in p53-mutated colon cancer cells through downregulation of Akt2 expression. Li J; Chen Y; Zhao J; Kong F; Zhang Y Cancer Lett; 2011 May; 304(1):52-9. PubMed ID: 21354697 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of Sec23A protein by miRNA-375 in prostate carcinoma. Szczyrba J; Nolte E; Wach S; Kremmer E; Stöhr R; Hartmann A; Wieland W; Wullich B; Grässer FA Mol Cancer Res; 2011 Jun; 9(6):791-800. PubMed ID: 21593139 [TBL] [Abstract][Full Text] [Related]
13. MiR-1 downregulation cooperates with MACC1 in promoting MET overexpression in human colon cancer. Migliore C; Martin V; Leoni VP; Restivo A; Atzori L; Petrelli A; Isella C; Zorcolo L; Sarotto I; Casula G; Comoglio PM; Columbano A; Giordano S Clin Cancer Res; 2012 Feb; 18(3):737-47. PubMed ID: 22179665 [TBL] [Abstract][Full Text] [Related]
14. MicroRNA145 targets BNIP3 and suppresses prostate cancer progression. Chen X; Gong J; Zeng H; Chen N; Huang R; Huang Y; Nie L; Xu M; Xia J; Zhao F; Meng W; Zhou Q Cancer Res; 2010 Apr; 70(7):2728-38. PubMed ID: 20332243 [TBL] [Abstract][Full Text] [Related]
15. Role of ribosomal protein RPS2 in controlling let-7a expression in human prostate cancer. Wang M; Hu Y; Amatangelo MD; Stearns ME Mol Cancer Res; 2011 Jan; 9(1):36-50. PubMed ID: 21148031 [TBL] [Abstract][Full Text] [Related]
16. MicroRNA-23b mediates urokinase and c-met downmodulation and a decreased migration of human hepatocellular carcinoma cells. Salvi A; Sabelli C; Moncini S; Venturin M; Arici B; Riva P; Portolani N; Giulini SM; De Petro G; Barlati S FEBS J; 2009 Jun; 276(11):2966-82. PubMed ID: 19490101 [TBL] [Abstract][Full Text] [Related]
17. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer. Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272 [TBL] [Abstract][Full Text] [Related]
18. Fibroblast growth factor-2 mediates transforming growth factor-beta action in prostate cancer reactive stroma. Yang F; Strand DW; Rowley DR Oncogene; 2008 Jan; 27(4):450-9. PubMed ID: 17637743 [TBL] [Abstract][Full Text] [Related]
19. MiRNA-451 plays a role as tumor suppressor in human glioma cells. Nan Y; Han L; Zhang A; Wang G; Jia Z; Yang Y; Yue X; Pu P; Zhong Y; Kang C Brain Res; 2010 Nov; 1359():14-21. PubMed ID: 20816946 [TBL] [Abstract][Full Text] [Related]
20. CXCL12/CXCR4 signaling activates Akt-1 and MMP-9 expression in prostate cancer cells: the role of bone microenvironment-associated CXCL12. Chinni SR; Sivalogan S; Dong Z; Filho JC; Deng X; Bonfil RD; Cher ML Prostate; 2006 Jan; 66(1):32-48. PubMed ID: 16114056 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]